uniQure (QURE) Current Leases (2019 - 2026)
uniQure (QURE) posted quarterly Current Leases of $3.0 million for Q2 2026, down 23.48% year-over-year from $3.9 million in Q2 2025, and little changed quarter-over-quarter from $3.0 million in Q1 2026.
Analysis
uniQure (QURE) Current Leases (2019 - 2026) Analysis & Trends
uniQure's Current Leases history runs 8 years deep, the most recent figure standing at $3.0 million for Q2 2026.
- In Q2 2026, Current Leases fell 23.48% year-over-year to $3.0 million; the TTM figure through Jun 2026 stood at $3.0 million (down 23.48% YoY), while the FY2025 annual figure was $3.9 million, up 7.25% from the prior year.
- Current Leases for Q2 2026 stood at $3.0 million, roughly flat from $3.0 million in the prior quarter.
- The five-year high for Current Leases was $8.4 million in Q4 2022, with the low at $3.0 million in Q2 2026.
- The 5-year median for Current Leases is $5.0 million (2022), against an average of $5.5 million.
- The sharpest annual moves came in 2022 and 2024: Current Leases soared 45.17% in 2022, then tumbled 56.84% in 2024.
- uniQure's Current Leases stood at $8.4 million in 2022, then declined by 0.45% to $8.3 million in 2023, then sank by 56.84% to $3.6 million in 2024, then advanced by 7.25% to $3.9 million in 2025, then retreated by 22.55% to $3.0 million in 2026.
- Business Quant data shows QURE's Current Leases at $3.0 million in Q2 2026, $3.0 million in Q1 2026, and $3.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 2.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.99 Mn |
| Mar 31, 2026 | 2.99 Mn |
| Dec 31, 2025 | 3.86 Mn |
| Sep 30, 2025 | 3.91 Mn |
| Jun 30, 2025 | 3.91 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Dec 31, 2024 | 3.60 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 3.63 Mn |
| Mar 31, 2024 | 8.00 Mn |
| Dec 31, 2023 | 8.34 Mn |
| Sep 30, 2023 | 7.89 Mn |
| Jun 30, 2023 | 7.78 Mn |
| Mar 31, 2023 | 7.67 Mn |
| Dec 31, 2022 | 8.38 Mn |
| Sep 30, 2022 | 6.43 Mn |
| Jun 30, 2022 | 6.51 Mn |
| Mar 31, 2022 | 5.75 Mn |
| Dec 31, 2021 | 5.77 Mn |
| Sep 30, 2021 | 5.80 Mn |